Par Drugs and Chemicals Limited is an India-based company engaged in manufacturing of active pharma ingredients (APIs) and fine chemicals for the domestic market as well as for exports to international markets. The Company manufactures a diverse range of antacid molecules. The Company’s products include magnesium hydroxide, magnesium trisilicate, magnesium carbonate, light magnesium oxide, magnesium oxide heavy, magnesium oxide USP, dried aluminum hydroxide gel, magaldrate, magnesium aluminum silicate hydrated, alma gate, hydrotalcite, aluminum hydroxide magnesium carbonate co-dried gel, aluminum-magnesium silicate BP, sodium aluminum silicate, precipitated silica, magnesium silicate, amorphous, colloidal silicon dioxide, and sucralfate USP. The Company owns and operates its manufacturing facilities at Bhavnagar in Gujarat. It has over four manufacturing blocks at Bhavnagar, which are for different products, having a capacity of approximately 9,700 metric tons per annum.
PAR DRUGS AND CHEM LTD Financial Highlights
- Revenue: PAR DRUGS AND CHEM LTD reported revenue of ₹107.66 crore in FY26 vs ₹103.12 crore in FY25. It showed an increase of 4.40% on a yearly basis.
- Operating Profit: PAR DRUGS AND CHEM LTD reported an operating profit of ₹17.30 crore in FY26 vs ₹17.92 crore in FY25. It showed a decrease of 3.46% on a year-on-year basis.
- Net Profit: PAR DRUGS AND CHEM LTD reported a net profit of ₹13.11 crore in FY26 vs ₹13.36 crore in FY25. It showed a decrease of 1.87% on a yearly basis.
PAR DRUGS AND CHEM LTD Quarterly Result Highlights
- PAR DRUGS AND CHEM LTD reported revenue of ₹19.97 crore in Mar 2026, compared with ₹30.67 crore in Dec 2025, representing a decrease of 34.89% on a quarter-on-quarter (QoQ) basis.
- PAR DRUGS AND CHEM LTD reported an operating profit of ₹0.83 crore in Mar 2026, compared with ₹6.44 crore in Dec 2025, representing a decrease of 87.11% on a quarter-on-quarter (QoQ) basis.
- PAR DRUGS AND CHEM LTD reported a profit of ₹0.85 crore in Mar 2026, compared with ₹4.80 crore in Dec 2025, reflecting a decrease of 82.29% on a QoQ basis.
- The earnings per share (EPS) of PAR DRUGS AND CHEM LTD stood at ₹10.86 during Mar 2026.